Update from the 3rd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV.
Cofrancesco
Joseph
J
D045930:Anabolic Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D005260:Female; D013006:Growth Hormone / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D006943:Hyperglycemia / Q000150:complications / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007333:Insulin Resistance; D008060:Lipodystrophy / Q000150:complications* / Q000188:drug therapy; D008297:Male; D013959:Thyroid Diseases / Q000150:complications
D045930:Anabolic Agents; D007004:Hypoglycemic Agents; D013006:Growth Hormone